CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 22 filers reported holding CATALYST BIOSCIENCES INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $844,000 | -36.8% | 194,933 | -26.5% | 0.00% | -100.0% |
| Q1 2021 | $1,336,000 | +1249.5% | 265,157 | +1591.2% | 0.00% | – |
| Q4 2020 | $99,000 | +86.8% | 15,679 | +29.5% | 0.00% | – |
| Q3 2020 | $53,000 | -30.3% | 12,112 | -7.0% | 0.00% | – |
| Q2 2020 | $76,000 | +81.0% | 13,024 | +35.7% | 0.00% | – |
| Q1 2020 | $42,000 | -58.8% | 9,600 | -36.0% | 0.00% | – |
| Q4 2019 | $102,000 | -16.4% | 15,001 | -40.1% | 0.00% | – |
| Q3 2019 | $122,000 | -62.9% | 25,047 | -44.2% | 0.00% | – |
| Q2 2019 | $329,000 | -67.5% | 44,873 | -64.1% | 0.00% | -100.0% |
| Q1 2019 | $1,012,000 | +729.5% | 124,851 | +702.6% | 0.00% | – |
| Q4 2018 | $122,000 | -77.7% | 15,556 | -69.4% | 0.00% | – |
| Q3 2018 | $547,000 | +2.8% | 50,899 | +11.3% | 0.00% | – |
| Q2 2018 | $532,000 | +31.4% | 45,731 | +191.3% | 0.00% | – |
| Q1 2018 | $405,000 | +20150.0% | 15,698 | +10365.3% | 0.00% | – |
| Q4 2017 | $2,000 | +100.0% | 150 | -57.1% | 0.00% | – |
| Q3 2017 | $1,000 | -93.8% | 350 | -90.3% | 0.00% | – |
| Q2 2017 | $16,000 | – | 3,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Colorado Capital Management, Inc. | 34,165 | $12 | 0.01% |
| JOHNSON & JOHNSON | 66,951 | $23,540 | 0.01% |
| Kynam Capital Management, LP | 89,886 | $31,604 | 0.00% |
| Nantahala Capital Management | 67,800 | $23,838 | 0.00% |
| Virtu Financial LLC | 48,633 | $17 | 0.00% |
| Keebeck Wealth Management, LLC | 20,000 | $7,032 | 0.00% |
| MORGAN STANLEY | 76,098 | $26,756 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 144,028 | $50 | 0.00% |
| BlackRock Inc. | 153,657 | $54,026 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 55,043 | $19,353 | 0.00% |